BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
-1.32%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$168M
AUM Growth
+$168M
(-3%)
Cap. Flow
+$2.1M
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
74.37%
Holding
57
New
9
Increased
8
Reduced
4
Closed
3
Top Buys
| 1 |
Cullinan Oncology
CGEM
|
$2.51M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$1.94M |
| 3 |
Nektar Therapeutics
NKTR
|
$1.84M |
| 4 |
Elicio Therapeutics
ELTX
|
$1.1M |
| 5 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$670K |
Top Sells
Sector Composition
| 1 | Healthcare | 96.34% |
| 2 | Energy | 1.49% |
| 3 | Consumer Staples | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
YTEN
51
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| $238K | 0.14% |
18,952
| – | – |
|
52
BioCryst Pharmaceuticals
BCRX
$1.74B
| $203K | 0.12% |
20,000
| – | – |
|
53
TherapeuticsMD
TXMD
$12.8M
| $134K | 0.08% |
+100,000
| New | +$134K |
|
|
CNCE
54
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $100K | 0.06% |
+20,000
| New | +$100K |
|
|
ODT
55
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| – | – |
-20,000
| Closed | -$384K |
|
|
OXFD
56
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| – | – |
-170,303
| Closed | -$2.97M |
|
|
BMY.RT
57
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| – | – |
-1,105,313
| Closed | -$763K |
|